Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Open accessPublished version of a preprint
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 17 of the 28 sources its claims cite were checked for support.
Abstract
Abstract Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age‐related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post‐mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age‐related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent‐like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length‐independent telomere damage in cardiomyocytes activates the classical senescence‐inducing pathways, p21 CIP and p16 INK4a , and results in a non‐canonical senescence‐associated secretory phenotype, which is pro‐fibrotic and pro‐hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age‐related myocardial dysfunction and in the wider setting to ageing in post‐mitotic tissues.
Overview
CoChat Summary
## TL;DR
The paper argues that ageing cardiomyocytes acquire a senescent-like state through persistent telomere-associated DNA damage that is independent of telomere shortening, cell division, and telomerase activity. Clearing senescent cells in mice reduced cardiomyocyte hypertrophy and fibrosis, suggesting a therapeutic angle for age-related cardiac dysfunction.
## Key findings
- In mouse and human hearts, mean telomere-associated foci (TAF) per cardiomyocyte and the percentage of cardiomyocytes with TAF increased significantly with age, while total γH2A.X foci did not change with age.
- In purified cardiomyocytes from young (3 months) vs old (20 months) mice, RNA-seq found 416 differentially expressed genes; principal component analysis separated the groups with the first two components explaining 80.1% and 7.8% of variance.
- Aged cardiomyocytes upregulated senescence markers and hypertrophy-related genes: p16Ink4a, p21CIP, and p15Ink4b increased, and hypertrophy genes including Myh7 and Acta1 increased, but canonical SASP genes such as Il-1α, Il-1β, Il-6, Cxcl1, and Cxcl2 were not differentially expressed.
- Senescent-cell clearance improved cardiac structure: in aged INK-ATTAC mice, AP treatment reduced p16Ink4a- and eGFP-positive cells, reduced TAF in cardiomyocytes, reduced average cardiomyocyte cross-sectional area, and decreased fibrosis; navitoclax likewise significantly reduced hypertrophy and fibrosis in aged wild-type mice.
- Navitoclax increased evidence of cardiomyocyte renewal: EdU-labelled cardiomyocytes increased from 0.07% in vehicle controls to 0.23% with navitoclax.
## Methods
- The study combined in vivo ageing and intervention experiments in mice with human heart tissue from patients undergoing open-heart surgery for aortic stenosis, plus multiple cell culture systems (rat neonatal cardiomyocytes, mouse embryonic cardiomyocytes, H9C2 myoblasts, and AC10 cells).
- Telomere damage was assessed mainly by dual immuno-FISH for DDR proteins (γH2A.X, 53BP1) co-localised with telomeres, along with STED microscopy, ChIP-qPCR for γH2A.X at telomeres, SA-β-Gal staining, RNA-seq, and cytokine assays.
- Causality was tested using telomere-targeted damage (TRF1-FokI), oxidative stress/mitochondrial dysfunction models, and senescent-cell clearance via INK-ATTAC/AP20187 and the senolytic navitoclax (ABT263).
## Limitations
- The paper states that interphase telomere FISH does not identify telomeres on specific chromosomes or detect telomere-free ends; it also notes that with 3-μm tissue sections, the entirety of cardiomyocyte nuclei may not be captured.
- The authors note that although STED improved resolution, clusters of telomeres may still not be fully resolved.
- Evident from the text: several mechanistic links are correlative rather than definitively causal in vivo, and the authors explicitly say it remains possible that mitochondrial dysfunction is a consequence, rather than the cause, of telomere dysfunction.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 110 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Work by us and others previously demonstrated demonstrated that stress exposure leads to activation of a persistent DDR at telomeric regions”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Telomere damage is persistent in cardiomyocytes
What the sources say
- Supportedcites Fumagalli et al, 2012 matched to “Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation” (2012) source
The Results section on DDR markers during physiological ageing states that exposure to exogenous or endogenous DNA damage can produce breaks at telomeres that remain unrepaired, resulting in persistent DDR foci. This supports the claim when stress exposure refers to DNA-damaging stress. (LLM, conf=0.93)
- Supportedcites Hewitt et al, 2012 matched to “Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence” (2012) source
The paper reports that DNA damage foci induced by exogenous stress are preferentially located at telomeres and that persistent foci are associated with telomeres (Abstract). The Results section, “TAF are persistent in stress-induced senescence,” also reports enrichment of the DDR marker γH2A.X at telomere repeats 10 days after irradiation. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Coppé et al, 2008 matched to “Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor” (2008) source
The citation supports the description of these as pro-inflammatory SASP-associated genes, not the citing authors’ finding about young and aged cardiomyocytes. The paper describes inflammatory cytokines and chemokines as SASP components, including IL-6, and identifies IL-1α and IL-1β as SASP factors; the cardiomyocyte comparison is not attributed to it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS)”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Swanson et al, 2013 matched to “Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence” (2013) source
The Results section (‘Marked distension of satellite DNA in a subset of primary human fibroblasts’; page unavailable) identifies distended centromeric satellite signals using DNA hybridization. The section on senescent murine cells likewise reports distended centromeric signals and calls this change SADS. The age-dependent cardiomyocyte finding is explicitly the citing authors’ own observation (‘we also observed’), not a finding attributed to this source. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Supportedcites Sahin et al, 2011 matched to “Telomere dysfunction induces metabolic and mitochondrial compromise” (2011) source
The section “Telomere dysfunction represses PGC network and mitochondrial biogenesis” describes successive generations of telomerase-deficient mice with decreasing telomere reserves and reports reduced PGC-1α and PGC-1β expression in mice with severe telomere dysfunction. The Discussion states that these analyses established a link between telomere dysfunction and repression of PGC-dependent mitochondrial biogenesis. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites Chang et al, 2016 matched to “Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy” (2016) source
The Results (Fig. 3 legend, p. —) state 'Critically short telomeres lead to activation of p53, leading to decreased mitochondrial biogenesis' with reduced Pgc1α and Pgc1β transcripts, and the Results text concludes that 'critically shortened telomeres in dystrophin-deficient cardiomyocytes in conjunction with a DNA damage response block mitochondrial biogenesis.' The Discussion additionally describes the TERT G4 null mouse model of ubiquitous telomere shortening developing mitochondrial dysfunction 'because of p53-dependent inhibition of PGC1α/β,' and the Significance section summarizes reduced mitochondrial biogenesis via p53 activation in the humanized-telomere mdx4cv/mTR model. Thus the mouse-model attribution of short-telomere repression of PGC1α/β-mediated mitochondrial biogenesis is stated in our copy. (LLM, conf=0.90)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Partly supportedcites Baker et al, 2016 matched to “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan” (2016) sourceExperimental — accuracy not yet measured
The section “p16Ink4a-positive cells contribute to cardiac aging” (page not provided) reports no significant difference in resting echocardiographic measures between treated and untreated 18-month-old mice, and preserved cardiac stress tolerance after treatment. But the paper describes clearance of p16Ink4a-positive cells, not specifically the loss of senescent cardiomyocytes; the identified senescence-marker-positive cardiac cells include pericardial epithelial cells and fibroblasts and aortic-root smooth muscle cells. (LLM, conf=0.88)
- Could not verifycites Roos et al, 2016 matched to “Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice” (2016) sourceExperimental — accuracy not yet measured
The age-related vascular pathology section reports clearance of senescent cells from the aortic vessel wall and improved carotid artery relaxation in aged mice. The copy does not report loss of senescent cardiomyocytes or assess whether their loss adversely affects cardiac function (searched: cardiomyocytes, cardiac function, heart function, echocardiography). (LLM, conf=0.74)
- Partly supportedcites Demaria et al, 2017 matched to “Cellular senescence promotes adverse effects of chemotherapy and cancer relapse” (2017) sourceExperimental — accuracy not yet measured
In Results (“Inflammation, bone marrow recovery and heart function”; page unavailable), eliminating senescent cells after doxorubicin treatment almost completely prevented declines in cardiac function. But the paper says those cardiac senescent cells were primarily endothelial cells and fibroblast-like cells, not cardiomyocytes. It therefore does not establish that loss of senescent cardiomyocytes is harmless in aged mice. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims
Create a free account to see all 130 claims and to verify the 4 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 46
- The quote only partly states this claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“genetic and pharmacological clearance of p16-expressing senescent cells ameliorated heart functions in aged mice140.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [140]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice, despite having long telomeres and ubiquitous telomerase expression, show an age-dependent increase in dysfunctional telomeres in both proliferating and non-proliferating tissues20,34–37.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the levels of DDR markers and TAFs increase during ageing in different mammalian tissues.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clearance of senescent cells in aged mice improves heart functions and reduces the fraction of TAF-positive cardiomyocytes without a significant effect on mean telomere length36.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clearance of senescent cells in aged mice and in mice with atherosclerosis using genetic and pharmacological approaches improves vascular and myocardial function and attenuates age-dependent remodelling.25,27”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Hearts from mixed‐sex CJ57/BL6 mice were placed on a Langendorff setup.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Mixed‐sex C57BL/6 mice were analysed at either 3, 15, 20, 24 or 30 months of age.”
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Senescence-associated b -galactosidase activity assay SA-b -Gal activity assay was performed as described previously (Dimri et al , 1995).”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · cited 1×
“Telomere shortening has been proposed as a major inducer of senescence (Bodnar et al , 1998).”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationHucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060 · cited 1×
“The models were encoded in the Systems Biology Markup Language (SBML) modelling standard (Hucka et al , 2003) with the Python SBML shorthand tool (Wilkinson, 2011).”
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“…associated with a protein complex known as shelterin (de Lange, 2005), which facilitates the formation of a lariat-like structure to shield the exposed end of DNA (Griffith et al , 1999), thus protecting the ends of chromosomes from being recognised as DNA damage (d’Adda di Fagagna et al , 2003).”
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 3×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Furthermore, we found a significant increase in TAF in CMs from Polg mut/mut mice, a model of accelerated ageing due to mitochondrial dysfunction (Trifunovic et al , 2004; Fig 6G).”
Cited by
Items 101–200 of 523
Bloom, S. I., Liu, Y., Tucker, J. R., Islam, M. T., Machin, D. R., Abdeahad, H., Thomas, T. G., Bramwell, R. C., Lesniewski, L. A., & Donato, A. J. (2023) · Aging Cell · doi:10.1111/acel.13875 · Cited by 82
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J., & Singh, T. (2021) · Cells · doi:10.3390/cells10123367 · Cited by 76
“Senescence can also be triggered in terminally differentiated cells such as neurons [24–26], and cardiomyocytes [27,28].”
BackgroundJAK/STAT signaling in diabetic kidney disease
Liu, Y., Wang, W., Zhang, J., Gao, S., Xu, T., & Yin, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1233259 · Cited by 87
“p53/p21, an important cause of cell cycle arrest in senescence, can be activated in response to telomere depletion and oxidative stress (Gambino et al., 2013; Anderson et al., 2019; Barnes et al., 2019).”
BackgroundNon-canonical Functions of Telomerase Reverse Transcriptase: Emerging Roles and Biological Relevance
Thompson, C. A. H., & Wong, J. M. Y. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200131125110 · Cited by 73
Telomerase as a Therapeutic Target in Cardiovascular Disease
Hoffmann, J., Richardson, G. D., Haendeler, J., Altschmied, J., Andrés, V., & Spyridopoulos, I. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315695 · Cited by 72
Self-citationHallmarks of Skin Aging: Update
Jin, S., Li, K., Zong, X., Eun, S., Morimoto, N., & Guo, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0321 · Cited by 79
“Although shortened telomere plays a central role in telomere dysfunction-induced senescence, recent investigations reveal that a persistent DDR can also be activated at telomeres in cellular senescence, regardless of telomere length [8].”
BackgroundCell Senescence, Multiple Organelle Dysfunction and Atherosclerosis
Machado-Oliveira, G., Ramos, C., Marques, A. R. A., & Vieira, O. V. (2020) · Cells · doi:10.3390/cells9102146 · Cited by 80
“Post-mitotic cardiomyocyte senescence was recently reported to occur independently of telomere shortening and damage [37].”
BackgroundInfluentialSenolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice
Jia, K., Dai, Y., Liu, A., Li, X., Wu, L., Lu, L., Bao, Y., & Jin, Q. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000878 · Cited by 64
Cardiac senescence is alleviated by the natural flavone acacetin via enhancing mitophagy
Hong, Y., Wu, W., Song, F., Wu, C., Li, G., & Wang, Y. (2021) · Aging · doi:10.18632/aging.203163 · Cited by 68
Exercise Counters the Age-Related Accumulation of Senescent Cells
Zhang, X., Englund, D. A., Aversa, Z., Jachim, S. K., White, T. A., & LeBrasseur, N. K. (2022) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000302 · Cited by 63
“It also should be noted that telomere uncapping and DNA damage within telomeres can trigger senescence independent of changes in telomere length (5,6).”
BackgroundSelf-citationBESSE, S., Nadaud, S., Balse, E., & Pavoine, C. (2022) · Cells · doi:10.3390/cells11071249 · Cited by 74
“To maintain tissue homeostasis, the removal of senescent cells in a timely manner is crucial and pharmacological senolytic treatment using navitoclax has been shown to reduce hypertrophy and fibrosis in hearts from aged mice [204].”
BackgroundSenescence and tissue fibrosis: opportunities for therapeutic targeting
O’Reilly, S., Tsou, P., & Varga, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.012 · Cited by 72
Therapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 68
Farr, J. N., Kaur, J., Doolittle, M. L., & Khosla, S. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00619-x · Cited by 60
Roadmap for alleviating the manifestations of ageing in the cardiovascular system
Liberale, L., Tual-Chalot, S., Sedej, S., Ministrini, S., Georgiopoulos, G., Grunewald, M., Bäck, M., Bochaton-Piallat, M.-L., Boon, R. A., Ramos, G. C., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01130-5 · Cited by 59
“Mitochondria-derived ROS in aged cardiomyocytes trigger telomere DNA damage, which induces senescence and contributes to increased cardiac hypertrophy and fibrosis 65 .”
Self-citationSenescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 64
“Paradoxically, detrimental effects of senescence have also been reported in myocardial infarct [69] and dysfunction [70], cancer progression [71], metabolic dysfunction [72] and atherosclerosis [73, 74].”
BackgroundWu, L., Sowers, J. R., Zhang, Y., & Ren, J. T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac080 · Cited by 69
Chen, L., Yin, X., Zhao, Y., Chen, H., Tan, T., Yao, P., & Tang, Y. (2022) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2022-219142 · Cited by 58
Cardiovascular disease and the biology of aging
Moturi, S., Ghosh-Choudhary, S. K., & Finkel, T. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.04.005 · Cited by 56
Keratin intermediate filaments in the colon: guardians of epithelial homeostasis
Polari, L., Alam, C. M., Nyström, J. H., Heikkilä, T. R. H., Tayyab, M., Baghestani, S., & Toivola, D. M. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105878 · Cited by 67
Escape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 62
Telomeres, cellular senescence, and aging: past and future
Eppard, M., Passos, J. F., & Victorelli, S. G. (2023) · Biogerontology · doi:10.1007/s10522-023-10085-4 · Cited by 70
“…the genetic removal of p16 Ink4a -positive cells have been shown to reduce TAF in the aorta (Roos et al. 2016), liver (Ogrodnik et al. 2017), heart (Anderson et al. 2019), brain (Ogrodnik et al. 2019), bone (Chandra et al. 2020), and adipose tissue (Farr et al. 2023; Ogrodnik et al. 2019; Xu et…”
InfluentialSelf-citationTargeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
DNA damage responses in ageing
da Silva, P. F. L., & Schumacher, B. (2019) · Open Biology · doi:10.1098/rsob.190168 · Cited by 55
“Intriguingly, senescence-like phenotypes have been reported in postmitotic cells such as neurons [110], osteocytes [111], retinal cells [112], myofibres [104] and cardiomyocytes [113], among others, challenging the traditional view of senescence as a proliferation arrest-dependent programme.”
BackgroundA new model to investigate UVB-induced cellular senescence and pigmentation in melanocytes
Martic, I., Wedel, S., Jansen-Dürr, P., & Cavinato, M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111322 · Cited by 54
Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Amen, A. M., Fellmann, C., Soczek, K. M., Ren, S. M., Lew, R. J., Knott, G. J., Park, J. E., McKinney, A., Mancini, A., Doudna, J. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008772118 · Cited by 55
Martini, H., Iacovoni, J. S., Maggiorani, D., Dutaur, M., Marsal, D. J., Roncalli, J., Itier, R., Dambrin, C., Pizzinat, N., Mialet‐Perez, J., et al. (2019) · Aging Cell · doi:10.1111/acel.13015 · Cited by 51
“In the context of cardiac aging, elimination of p16 senescent cells using INK‐ATTAC mice or seno‐ lytic treatments prevented age‐related cardiac remodeling and SASP factors production (Anderson et al., 2019; Baker et al., 2016; Lewis‐ McDougall et al., 2019; Walaszczyk et al., 2019).”
BackgroundSelf-citationTelomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 68
“TIFs can also occur independently from telomere shortening 27 , but such TIFs have not yet been associated with TBDs.”
InfluentialAin, Q., Schmeer, C., Wengerodt, D., Witte, O. W., & Kretz, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072477 · Cited by 52
“, induced by ROS-dependent DNA damage [151,152], might increase the load of ECTR T- or C-circles, e.”
BackgroundVgrG-dependent effectors and chaperones modulate the assembly of the type VI secretion system
Liang, X., Pei, T., Li, H., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010116 · Cited by 51
Extracellular citrate and metabolic adaptations of cancer cells
Parkinson, E. K., Adamski, J., Zahn, G., Gaumann, A. K. A., Flores‐Borja, F., Ziegler, C. M., & Mycielska, M. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10007-1 · Cited by 53
Modern Concepts in Cardiovascular Disease: Inflamm-Aging
Puspitasari, Y. M., Ministrini, S., Schwarz, L., Karch, C., Liberale, L., & Camici, G. G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.882211 · Cited by 61
“Indeed, clearance of senescent cells significantly reduces cardiac hypertrophy and fibrosis (Anderson et al., 2019).”
BackgroundCardiovascular aging: spotlight on mitochondria
Ali, M. A., Gioscia‐Ryan, R. A., Yang, D., Sutton, N. R., & Tyrrell, D. J. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00632.2023 · Cited by 59
Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases
Kumar, M., Yan, P., Kuchel, G. A., & Xu, M. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.12.003 · Cited by 69
Age-related testosterone decline: mechanisms and intervention strategies
Cheng, H., Zhang, X., Li, Y., Cao, D., Luo, C., Zhang, Q., Zhang, S., & Jiao, Y. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01316-5 · Cited by 77
DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders
Provasek, V. E., Mitra, J., Malojirao, V. H., & Hegde, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094653 · Cited by 55
Hou, J., Lin, Y., Zhu, C., Chen, Y., Lin, R., Lin, H., Liu, D., Guan, D., Yu, B., Wang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202402477 · Cited by 63
Senotherapeutics: Targeting senescent cells for the main age-related diseases
Boccardi, V., & Mecocci, P. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111526 · Cited by 58
Therapeutic opportunities for senolysis in cardiovascular disease
Sweeney, M., Cook, S. A., & Gil, J. (2022) · FEBS Journal · doi:10.1111/febs.16351 · Cited by 56
Lazzarini, E., Lodrini, A. M., Arici, M., Bolis, S., Vagni, S., Panella, S., Rendon-Angel, A., Saibene, M., Metallo, A., Torre, T., et al. (2022) · Theranostics · doi:10.7150/thno.70884 · Cited by 57
“The latter may contribute to age-related cardiac dysfunction as SenCM-associated SASPs including GDF15 and TGFB2 have been associated with myofibroblast activation and CMs hypertrophy [72].”
BackgroundMG53 suppresses NF-κB activation to mitigate age-related heart failure
Wang, X., Li, X., Ong, H., Tan, T., Park, K. H., Bian, Z., Zou, X., Haggard, E., Janssen, P. M. L., Merritt, R. E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148375 · Cited by 46
“Aging is also 5 associated with increased proportion of senescent cells which contribute to inflammation through 6 senescence-associated secretory phenotype production (43).”
BackgroundThe Aging Heart: A Molecular and Clinical Challenge
Lazzeroni, D., Villatore, A., Souryal, G., Pili, G., & Peretto, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416033 · Cited by 62
“Telomere ablation, as well as length-independent telomere damage, possibly due to oxidative stress, is responsible for age-related cardiac dysfunction [51].”
BackgroundAre immunosenescent T cells really senescent?
Slaets, H., Veeningen, N., de Keizer, P. L. J., Hellings, N., & Hendrix, S. (2024) · Aging Cell · doi:10.1111/acel.14300 · Cited by 62
“Evidenced by critically short telomeres, persistent γ H2AX DNA damage foci/ DNA-SCARS/TAFs (Allsopp & Harley, 1995; Anderson et al., 2019; d'Adda di Fagagna et al., 2003; Rodier et al., 2011) Unclear.”
BackgroundMajor depression and enhanced molecular senescence abnormalities in young and middle-aged adults
Diniz, B. S., Reynolds III, C. F., Sibille, E., Bot, M., & Penninx, B. W. J. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0541-3 · Cited by 45
Li, Y., Liu, M., Song, X., Zheng, X., Yi, J., Liu, D., Wang, S., Chu, C., & Yang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01150 · Cited by 46
Li, C., Jiang, S., Wang, H., Wang, Y., Han, Y., & Jiang, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113097 · Cited by 51
Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease
Nieto, M., Königsberg, M., & Silva‐Palacios, A. (2023) · Biogerontology · doi:10.1007/s10522-023-10068-5 · Cited by 53
Stoicescu, L., Crișan, D., Morgovan, C., Avram, L., & Ghibu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020794 · Cited by 65
Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types
Limbad, C., Doi, R., McGirr, J., Ciotlos, S., Perez, K., Clayton, Z. S., Daya, R., Seals, D. R., Campisi, J., & Melov, S. (2022) · iScience · doi:10.1016/j.isci.2022.103848 · Cited by 45
“…ABT263 (ABT) improves age-associated pathologies, including declines in hematopoiesis and cognition, diabetes, and myocardial infarction (Aguayo-Mazzucato et al., 2019; Bussian et al., 2018; Chang et al., 2016; Gonzalez-Gualda et al., 2020; Kirkland and Tchkonia, 2017; Walaszczyk et al., 2019).”
BackgroundCell senescence in cardiometabolic diseases
Grootaert, M. O. J. (2024) · npj Aging · doi:10.1038/s41514-024-00170-4 · Cited by 61
“2) 122 .”
BackgroundInfluentialLiu, D., Richardson, G. D., Benli, F. M., Park, C., de Souza, J. V. B., Bronowska, A. K., & Spyridopoulos, I. (2020) · Clinical Science · doi:10.1042/cs20191213 · Cited by 51
Self-citationO’Hara, S. P., Splinter, P. L., Trussoni, C. E., Guicciardi, M. E., Splinter, N. P., Alsuraih, M., Nasser‐Ghodsi, N., Stollenwerk, D., Gores, G. J., & LaRusso, N. F. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010176 · Cited by 43
“The inciting events triggering withdrawal from the cell cycle include strong mitogenic or oncogenic signals, and telomeric and/or non-telomeric DNA damage [9,11-13].”
BackgroundPini, M., Czibik, G., Sawaki, D., Mezdari, Z., Braud, L., Delmont, T., Mercedes, R., Martel, C., Buron, N., Marcelin, G., et al. (2021) · Aging Cell · doi:10.1111/acel.13421 · Cited by 43
“…initiation of HFD as demonstrated by the increase of a combination of senescence markers (SA- β- gal activity, CDKN1a, and CDKN2a) (Ogrodnik et al., 2019) together with adipocyte hypertrophy, as recently reported in other cell types (Anderson et al., 2019; Biran et al., 2017; Neurohr et al., 2019).”
BackgroundSaul, D., Doolittle, M. L., Rowsey, J. L., Froemming, M. N., Kosinsky, R. L., Vos, S. J., Ruan, M. M., LeBrasseur, N. K., Chandra, A., Pignolo, R. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179834 · Cited by 49
Self-citationCardiomyocyte senescence and the potential therapeutic role of senolytics in the heart
Zhai, P., & Sadoshima, J. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.06 · Cited by 51
Martin-Ruiz, C. M., Hoffmann, J., Shmeleva, E. V., von Zglinicki, T., Richardson, G. D., Draganova, L., Redgrave, R. E., Collerton, J. C., Arthur, H. M., Keavney, B. D., et al. (2020) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-019-0041-y · Cited by 49
Self-citationRedd1 knockdown prevents doxorubicin-induced cardiac senescence
Huang, P., Bai, L., Liu, L., Fu, J. F., Wu, K., Liu, H., Liu, Y., Qi, B., & Qi, B. (2021) · Aging · doi:10.18632/aging.202972 · Cited by 47
“This leads to interstitial fibrosis and hypertrophy of cardiomyocytes [19], i.e., the defining characteristic of pathological cardiac remodeling and dysfunction [56].”
Monoamine oxidases: A missing link between mitochondria and inflammation in chronic diseases ?
Beucher, L., Gabillard-Lefort, C., Baris, O. R., & Mialet‐Perez, J. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103393 · Cited by 47
Self-citationGenome-Protecting Compounds as Potential Geroprotectors
Proshkina, E., Shaposhnikov, M. V., & Moskalev, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124484 · Cited by 45
“Internal triggers include replicative exhaustion [121] and telomere erosion [109], DNA damage [122], chromosomal instability [123], ROS [124], activation of oncogenes [125] and some other factors [93,115].”
BackgroundBloom, S. I., Tucker, J. R., Lim, J., Thomas, T. G., Stoddard, G. J., Lesniewski, L. A., & Donato, A. J. (2022) · GeroScience · doi:10.1007/s11357-022-00681-6 · Cited by 49
Cardiovascular aging: from cellular and molecular changes to therapeutic interventions
Vakka, A., Warren, J. S., & Drosatos, K. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.09 · Cited by 68
Senescent endothelial cells: a potential target for diabetic retinopathy
Liao, Y.-L., Fang, Y., Sun, J., & Dou, G. (2024) · Angiogenesis · doi:10.1007/s10456-024-09943-7 · Cited by 45
“Oxidative DNA damage often occurs at telomeres [82, 83], which can lead to telomere uncapping [84, 85], telomere shortening and length-independent telomere damage [ 86 ].”
Focus on senescence: Clinical significance and practical applications
Boccardi, V., Orr, M. E., Polidori, M. C., Ruggiero, C., & Mecocci, P. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13775 · Cited by 45
“Mitochondrial ROS can accelerate DNA damage and eventually lead to premature senescence [43], and several strategies targeting oxidative stress on which senescent cells depend have been shown to prevent CS and promote healthy aging [44, 45].”
BackgroundJiang, T., Ruan, N., Luo, P., Wang, Q., Wei, X., Li, Y., Dai, Y., Li, L., Lv, J., Liu, Y., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102320 · Cited by 49
“Previous research has demonstrated that oxidative stress accumulates with aging, leading to cardiomyocyte senescence and age-related cardiac remodeling (Anderson et al., 2019).”
BackgroundCardiac ageing: from hallmarks to therapeutic opportunities
Hastings, M. H., Zhou, Q., Wu, C., Shabani, P., Huang, S., Yu, X., Singh, A. P., Guseh, J. S., Li, H., Lerchenmüller, C., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae124 · Cited by 53
Senescent cells in human adipose tissue: A cross‐sectional study
Espinosa De Ycaza, A. E., Søndergaard, E., Morgan‐Bathke, M., Carranza Leon, B. G., Lytle, K. A., Ramos, P., Kirkland, J. L., Tchkonia, T., & Jensen, M. D. (2021) · Obesity · doi:10.1002/oby.23202 · Cited by 39
“There is evidence that some nondividing cardiomyocytes can become senescent- like (20).”
BackgroundSelf-citationMetabolic Alterations in Cellular Senescence: The Role of Citrate in Ageing and Age-Related Disease
Mycielska, M. E., James, E. N., & Parkinson, E. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073652 · Cited by 40
“In addition, a phenotype resembling cellular senescence occurs in post-mitotic tissues such as the liver and brain, following cellular stress and during chronological aging [11,12] but this is now thought to be a distinct phenotype and is termed ‘Long-lived post mitotic ageing’ see [11] for a recent review.”
BackgroundRole of senescence in the chronic health consequences of COVID-19
Wissler Gerdes, E. O., Vanichkachorn, G., Verdoorn, B. P., Hanson, G. J., Joshi, A. Y., Murad, M. H., Rizza, S. A., Hurt, R. T., Tchkonia, T., & Kirkland, J. L. (2022) · Translational Research · doi:10.1016/j.trsl.2021.10.003 · Cited by 38
Self-citationSenescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 51
“For example, neurons and cardiomyocytes have been shown to express markers of senescence, suggesting that cell cycle competence may not be required for at least some aspects of the senescent phenotype (Anderson et al., 2019; Herdy et al., 2022; Jurk et al., 2012).”
BackgroundFalcão‐Pires, I., Ferreira, A. F., Trindade, F., Bertrand, L., Ciccarelli, M., Visco, V., Dawson, D. K., Hamdani, N., Laake, L. W. V., Lezoualc’h, F., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3264 · Cited by 50
The functional impact of nuclear reorganization in cellular senescence
Rocha, A., Dalgarno, A., & Neretti, N. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab012 · Cited by 38
Epigenetic dysregulation in cardiovascular aging and disease
Herman, A. B., Occean, J. R., & Sen, P. (2021) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.16 · Cited by 46
“Zheng Z, Chen H, Li J, et al. Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin.”
BackgroundInfluentialRadiation induces primary osteocyte senescence phenotype and affects osteoclastogenesis in vitro
Wang, Y., Xu, L., Wang, J., Bai, J., Zhai, J., & Zhu, G. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4909 · Cited by 44
The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments
Batista, N. J., Desai, S. G., Perez, A. M., Finkelstein, A., Radigan, R., Singh, M., Landman, A., Drittel, B., Abramov, D., Ahsan, M., et al. (2023) · Genes · doi:10.3390/genes14030602 · Cited by 48
“Further parallels between premature aging in HGPS and normal aging include dysfunction at telomeres as well as premature senescence [79,80].”
BackgroundTelomeres as hotspots for innate immunity and inflammation
Nassour, J., Przetocka, S., & Karlseder, J. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103591 · Cited by 42
Consequences of telomere replication failure: the other end-replication problem
Brenner, K. A., & Nandakumar, J. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.03.013 · Cited by 36
Plasma Proteomics of COVID-19–Associated Cardiovascular Complications
Roh, J. D., Kitchen, R. R., Guseh, J. S., McNeill, J. N., Aïd, M., Martinot, A. J., Yu, A., Platt, C., Rhee, J., Weber, B., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.01.013 · Cited by 53
Senopathies-Diseases Associated with Cellular Senescence
Lushchak, O., Schosserer, M., & Grillari, J. (2023) · Biomolecules · doi:10.3390/biom13060966 · Cited by 35
Anti-ageing interventions for the treatment of cardiovascular disease
Abdellatif, M., Schmid, S., Fuerlinger, A., & Kroemer, G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae177 · Cited by 52
“161 That said, senolytic therapy using a combination of dasatinib and quercetin prevented age-induced denervation, thereby reducing electrical instability and preserving heart rate patterns in female and male mice.”
Diwan, B., & Sharma, R. (2022) · Food Science and Biotechnology · doi:10.1007/s10068-022-01114-y · Cited by 39
The gliadin p31–43 peptide: Inducer of multiple proinflammatory effects
Chirdo, F. G., Auricchio, S., Troncone, R., & Barone, M. V. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.10.003 · Cited by 37
Context‐dependent roles of cellular senescence in normal, aged, and disease states
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2023) · The FEBS Journal · doi:10.1111/febs.16573 · Cited by 34
DNA methylation and histone variants in aging and cancer
Mangelinck, A., & Mann, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.06.002 · Cited by 41
Schulz, R., & Schlüter, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076459 · Cited by 35
“When transgenic animals are treated with the antioxidant N-acetyl cysteine part of the above effects can be rescued [136,184].”
BackgroundWang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 42
“…or telomere shortening, for example, induces an early-onset cardiovascular aging phenotype in mice, characterized by premature myocardial hypertrophy, fibrosis, and diastolic dysfunction, as well as vascular oxidative stress, endothelial dysfunction, and increased blood pressure [172,173].”
BackgroundOxidative-stress-induced telomere instability drives T cell dysfunction in cancer
Rivadeneira, D. B., Thosar, S. A., Quann, K., Gunn, W. G., Dean, V. G., Xie, B., Parise, A. M., McGovern, A. C., Spahr, K., Lontos, K., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.08.008 · Cited by 44
The role of telomeres and telomerase in the senescence of postmitotic cells
Pańczyszyn, A., Boniewska‐Bernacka, E., & Goc, A. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102956 · Cited by 37
Telomeres and telomerase in risk assessment of cardiovascular diseases
Boniewska-Bernacka, E., Pańczyszyn, A., & Klinger, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112361 · Cited by 31
Recent advances on the role of monoamine oxidases in cardiac pathophysiology
Kaludercic, N., Arusei, R. J., & Lisa, F. D. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01012-2 · Cited by 36
“Furthermore, these cells also secreted senescence-associated secretory phenotype (SASP)-like signaling molecules that induced senescence in other cell types [3].”
BackgroundPotential Clinical Implications of Senotherapies for Cardiovascular Disease
Suda, M., Katsuumi, G., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0657 · Cited by 39
Self-citationMłynarska, E., Kowalik, A., Krajewska, A., Krupińska, N., Marcinkowska, W., Motor, J., Przybylak, A., Tłustochowicz, K., Rysz, J., & Franczyk, B. (2025) · Biomolecules · doi:10.3390/biom15101452 · Cited by 41
“Senescent cardiomyocytes adopt a SASP driving inflammation and fibrotic remodeling through fibroblast activation [41,46].”
Senescence Alterations in Pulmonary Hypertension
Roger, I., Milara, J., Belhadj, N., & Cortijo, J. (2021) · Cells · doi:10.3390/cells10123456 · Cited by 40
Telomeres: beacons of autocrine and paracrine DNA damage during skin aging
Victorelli, S. G., & Passos, J. F. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1728016 · Cited by 36
“Activation of DDR signaling at telomeres that are not critically short has also been shown in other non-dividing cells such as neurons [51] and cardiomyocytes [11].”
BackgroundInfluentialSelf-citationMethods to study circRNA-protein interactions
Ulshöfer, C. J., Pfafenrot, C., Bindereif, A., & Schneider, T. P. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.014 · Cited by 31
Ishaq, A., Tchkonia, T., Kirkland, J. L., Siervo, M., & Saretzki, G. C. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111798 · Cited by 34
“The lack of many SASP factors from isolated, cultured cells compared to (heart) tissue has also been described in the case of cardiomyocytes (Anderson et al., 2019).”
Self-citationDiabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality
Lezoualc’h, F., Badimón, L., Baker, H. E., Bernard, M., Czibik, G., de Boer, R. A., d’Humières, T., Kergoat, M., Kowala, M. C., Rieusset, J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac152 · Cited by 33
Oxidative Stress and DNA Damage at Telomeres
Opresko, P. L., Sanford, S. L., & De Rosa, M. (2025) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041707 · Cited by 30
Mehdizadeh, M., Naud, P., Abu-Taha, I., Hiram, R., Xiong, F., Xiao, J., Saljic, A., Kamler, M., Vuong, N., Thorin, É., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae003 · Cited by 33
Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging
Odawara, T., Yamauchi, S., & Ichijo, H. (2024) · Communications Biology · doi:10.1038/s42003-024-06386-0 · Cited by 30
“Notably, these diseases have also been reported to be associated with senescence 29 – 31 .”
Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction
Tobin, S. W., Alibhai, F. J., Weisel, R. D., & Li, R. (2020) · Cells · doi:10.3390/cells9081894 · Cited by 35
Metadata
- Authors
- Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., Proctor, C., Correia‐Melo, C., Victorelli, S., Fielder, E., Berlinguer‐Palmini, R., Owens, A., Greaves, L. C., Kolsky, K. L., Parini, A., Douin‐Echinard, V., LeBrasseur, N. K., Arthur, H. M., Tual‐Chalot, S., Schafer, M. J., Roos, C. M., Miller, J. D., Robertson, N., Mann, J., Adams, P. D., Tchkonia, T., Kirkland, J. L., Mialet‐Perez, J., Richardson, G. D., & Passos, J. F.
- Affiliations
- Newcastle University (GB)
- Inserm (FR)
- Mayo Clinic (US)
- Wellcome Centre for Mitochondrial Research (GB)
- Cancer Research UK Scotland Institute (GB)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- ORCID
- Lagnado, Anthony
- Maggiorani, Damien
- Walaszczyk, Anna
- Dookun, Emily
- Chapman, James
- Birch, Jodie
- Salmonowicz, Hanna
- Ogrodnik, Mikolaj
- Jurk, Diana
- Proctor, Carole
- Correia‐Melo, Clara
- Victorelli, Stella
- Fielder, Edward
- Berlinguer‐Palmini, Rolando
- Greaves, Laura C
- Parini, Angelo
- Douin‐Echinard, Victorine
- LeBrasseur, Nathan K
- Arthur, Helen M
- Tual‐Chalot, Simon
- Schafer, Marissa J
- Miller, Jordan D
- Robertson, Neil
- Mann, Jelena
- Adams, Peter D
- Kirkland, James L
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- Venue
- The EMBO Journal
- Published
- 2019-02-08
- Volume
- 38
- Issue
- 5
- Pages
- e100492
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC6396144
- OpenAlex
- W2913284769
- Semantic Scholar
- f2b575f4b8dabea90337c591a95d86658c57701d
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 59 · 2025: 80 · 2024: 83 · 2023: 68 · 2022: 77 · 2021: 70 · 2020: 67 · 2019: 28
- FWCI
- 41.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Connor Group
- Noaber Foundation
- Région Occitanie, France
- Medical Research Council and Arthritis UK funded centre for integrated Musculoskeletal Ageing (MR/K0063121/1)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/H022384/1, BB/K017314/1)
- British Heart Foundation (PG/15/85/31744)
- Foundation for the National Institutes of Health (AG013925)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- cardiomyocyte senescence, cellular senescence, cardiac aging, senolytics, senescence-associated secretory phenotype, p21, p16INK4a, mitochondrial dysfunction, myocardial fibrosis, cardiac hypertrophy, age-related cardiac dysfunction
- MeSH terms
- Aging, Animals, DNA Damage, Female, Fibrosis, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitosis, Monoamine Oxidase, Phenotype, RNA, Cellular Senescence, Rats, Sprague-Dawley, Mice, Knockout, Telomerase, Myocytes, Cardiac, Mice, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.